Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience.

Konstantinos Vrontis Sofia C Economidou George Fotopoulos

Published in: Cancer investigation (2021)

Comparing our findings with other retrospective and prospective studies, it seems that the systematic treatment of choice and management in L-LCNEC of the lung should be that of a small cell carcinoma of the lung.

Keyphrases

small cell lung cancer
squamous cell carcinoma
single cell
cell therapy
cross sectional